
|Articles|April 1, 2006
Lessons That Stick in Your Mind
Learn from the mistakes of your colleagues--don't end up in the emergency room for an accidental needle stick!
Advertisement
We can all learn from the mistakes of our colleagues. Here is a sampling of explanations offered by health care providers who visited the emergency department for needle stick wounds:
"When I was closing the safety tip on an arterial blood gas needle, the needle flipped out of the syringe and landed on my finger."
"I didn't look closely at the sharps box, and there was a needle sticking out."
"The patient moved when I was inserting a central line. I should have used soft restraints."
"I was suturing and a nurse came in and asked me a question. When I looked away, I poked myself."
- D. Brady Pregerson, MD
Los Angeles
Advertisement
Related to this article

Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.

Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.

TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.

Investigational CagriSema produced 23.1% to 26.7% weight loss across menopause stages at 68 weeks, with improvements in cardiometabolic risk factors.

An EHR-integrated tool matched manual CKD and cardiovascular risk assessments in 60 patients and showed promise for improving risk-based kidney care in primary care.

TMS 2026: Nearly 67% of US women receiving elinzanetant achieved at least a 50% reduction in menopausal VMS frequency by week 12 in pooled phase 3 trial data.

TMS 2026: Only 21.7% of women initiated menopause hormone therapy, with significant racial disparities and low treatment persistence, a new study finds.
Advertisement
Advertisement
Trending on Patient Care Online
1
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
2
New Study Finds Low Initiation, Persistence With Menopause Hormone Therapy
3
Elinzanetant Reduced Menopausal VMS Frequency by ≥50% in 67% of Women at Week 12: TMS 2026
4
Night Sweats in Midlife Women: A Q&A With Cheryl Cox Kinney, MD
5

